<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004039A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004039</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13920693</doc-number><date>20130618</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>7</main-group><subgroup>64</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>51</main-group><subgroup>08</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>5</main-group><subgroup>08</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>7</main-group><subgroup>64</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>5</main-group><subgroup>08</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>51</main-group><subgroup>08</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>424  169</main-classification><further-classification>530330</further-classification><further-classification>530321</further-classification><further-classification>514 218</further-classification><further-classification>435 29</further-classification></classification-national><invention-title id="d0e43">RGD MIMETIC y-AAPEPTIDES AND METHODS OF USE</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61667035</doc-number><date>20120702</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Cai</last-name><first-name>Jianfeng</first-name><address><city>Tampa</city><state>FL</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Niu</last-name><first-name>Youhong</first-name><address><city>Tampa</city><state>FL</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Cai</last-name><first-name>Weibo</first-name><address><city>Madison</city><state>WI</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Hong</last-name><first-name>Hao</first-name><address><city>Madison</city><state>WI</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Cai</last-name><first-name>Jianfeng</first-name><address><city>Tampa</city><state>FL</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Niu</last-name><first-name>Youhong</first-name><address><city>Tampa</city><state>FL</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Cai</last-name><first-name>Weibo</first-name><address><city>Madison</city><state>WI</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Hong</last-name><first-name>Hao</first-name><address><city>Madison</city><state>WI</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Wisconsin Alumni Research Foundation</orgname><role>02</role><address><city>Madison</city><state>WI</state><country>US</country></address></addressbook></assignee><assignee><addressbook><orgname>University of South Florida (A Florida Non-Profit Corporation)</orgname><role>02</role><address><city>Tampa</city><state>FL</state><country>US</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Embodiments of the present disclosure provide for RGD mimetic &#x3b3;-AApeptide compounds, &#x3b3;-AApeptide compounds capable of binding an RGD binding site on integrin &#x3b1;<sub>v</sub>&#x3b2;<sub>3</sub>, linear &#x3b3;-AApeptide compounds, cyclic &#x3b3;-AApeptide compounds and multimeric RGD mimetic &#x3b3;-AApeptide compounds, methods of making each, and methods of using each, and the like. In embodiments, the RGD mimetic &#x3b3;-AApeptide compounds can be used in imaging, diagnostics, and treatment of angiogenesis related conditions.</p></abstract></us-patent-application>